サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1555535

組織診断市場：技術別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Tissue Diagnostics Market, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 360 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
組織診断市場：技術別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月20日
発行: AnalystView Market Insights
ページ情報: 英文 360 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

組織診断市場規模は2023年に54億5,634万米ドルとなり、2024年から2032年にかけてCAGR 8.4%で拡大

組織診断市場- 市場力学

がん罹患率の増加が市場拡大を促進すると予測されます。世界のがん罹患率の上昇に伴い、腫瘍を効果的に同定し特徴付けることができる高度な診断ツールに対する需要が高まっています。生検分析、免疫組織化学、分子検査などの方法を含む組織診断は、がんの診断、病期分類、治療計画に不可欠です。National Center for Health Statisticsによると、2023年には米国で新たに195万8310人のがん患者が発生し、60万9820人ががんに関連して死亡すると推定されています。

政府・民間両部門によるがん研究への資金提供や診断技術の開発は、市場の成長をさらに刺激する可能性があります。とはいえ、データプライバシーに関する懸念が市場に課題をもたらす可能性もあります。

組織診断市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約8.4%のCAGRで毎年成長すると推定されます。

技術セグメンテーションに基づくと、免疫組織化学が2023年に最大の市場シェアを示すと予測されました。

用途別では、2023年に乳がんが主要なタイプでした。

エンドユーザー別では、2023年に病院が主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

組織診断市場-セグメンテーション分析：

世界の組織診断市場は、技術、用途、エンドユーザー、地域によって区分されます。

市場セグメンテーションは、技術別に免疫組織化学、In Situ Hybridization、一次染色・特殊染色、デジタル病理・ワークフローの3つに分類されます。免疫組織化学は市場で主導的地位を占めています。免疫組織化学は組織診断において極めて重要であり、疾患、特にがんの診断のための組織サンプルの徹底的な分析を容易にし、治療の意思決定を支援します。

市場は用途によって5つのカテゴリーに区分される：乳がん、非小細胞肺がん、前立腺がん、胃がん、その他です。乳がんは市場の主導的地位を占めています。乳がんの組織診断分野は、罹患率の上昇、技術の進歩、早期発見と個別化治療アプローチの重視によって推進されています。

市場はエンドユーザーによって3つのカテゴリーに区分される：病院、調査研究所、製薬会社、CRO（医薬品開発業務受託機関）です。市場では病院が圧倒的な地位を占めています。病院における組織診断の需要は、正確かつ迅速な病気の診断と管理の必要性によって推進されています。

組織診断市場-地理的洞察

この市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカを含む広範な地域にまたがっています。これらの地域は、ビジネス展望に貢献している国々に基づいてさらに分類されます。北米が市場をリードしている主な理由は、機器や試薬を含む高度な診断製品に対する高い需要です。北米では、自動化システム、デジタル病理学プラットフォーム、高度な分子診断装置など、高い精度と効率を保証する高度な診断ツールや試薬に対する要求が顕著です。体外診断（IVD）市場の大部分は先進国、特に米国に集中しており、約190億米ドルを占めています。

欧州も組織診断分野で重要な役割を果たしており、がん罹患率の上昇、高度なヘルスケアインフラ、早期診断の重要性に対する意識の高まりに後押しされて着実な成長を遂げています。

組織診断市場-競合情勢：

組織診断市場は、革新的なソリューション、多様な製品の提供、戦略的イニシアティブを通じて市場シェアの確保に努める数多くの有力企業や新興企業によって特徴づけられるように、高いレベルの競争を示しています。組織は、デジタル病理学、自動染色システム、高感度試薬などの最先端技術の進歩に資源を投入しています。強固な世界拠点と確立された販売チャネルを持つ企業は、さまざまな地域市場で効果的に競争できる立場にあります。さらに、組織診断分野での存在感を高めるため、新たな地理的領域の開拓や製品ラインの拡充にも注力しています。

目次

第1章 組織診断市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 組織診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 組織診断産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 組織診断市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 組織診断市場情勢

  • 組織診断市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 組織診断市場- 技術別

  • 概要
    • 技術別セグメントシェア分析
    • 免疫組織化学
      • 機器
      • スライド染色システム
      • 組織マイクロアレイ
      • 組織処理システム
      • スライドスキャナ
      • その他の製品
      • 消耗品
      • 抗体
      • 試薬
      • キット
    • インサイチューハイブリダイゼーション
      • 機器
      • 消耗品
      • ソフトウェア
    • 一次染色と特殊染色
    • デジタル病理学とワークフロー
      • スライド全体のイメージング
      • 画像解析情報学
      • 情報管理システムの保管と通信
      • 解剖病理学
    • 機器
      • ミクロトームとクライオスタットミクロトーム
      • 組織処理装置
      • 自動ストレーナー
      • その他の製品
    • 消耗品
      • 試薬と抗体
      • プローブとキット
      • その他

第8章 組織診断市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 乳がん
    • 非小細胞肺がん
    • 前立腺がん
    • 胃がん
    • その他

第9章 組織診断市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 研究ラボ
    • 製薬団体
    • 受託約研究機関（CRO）

第10章 組織診断市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 組織診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • Siemens
    • Danaher
    • bioMerieux SA
    • QIAGEN
    • BD
    • Merck KGaA
    • GE Healthcare
    • BioGenex
    • Cell Signaling Technology, Inc.
    • Bio SB
    • DiaGenic ASA
    • Agilent Technologies
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV3607

REPORT HIGHLIGHT

Tissue Diagnostics Market size was valued at USD 5,456.34 million in 2023, expanding at a CAGR of 8.4% from 2024 to 2032.

Tissue diagnostics play a crucial role in contemporary medicine, encompassing the analysis of tissue specimens to identify diseases, inform treatment strategies, and assess patient well-being. This discipline incorporates various fundamental techniques and technologies that are indispensable for precise diagnosis and efficient treatment planning.

Tissue Diagnostics Market- Market Dynamics

The increasing incidence of cancer is anticipated to propel market expansion. As cancer rates rise worldwide, there is an escalating demand for sophisticated diagnostic tools that can effectively identify and characterize tumors. Tissue diagnostics, which encompass methods such as biopsy analysis, immunohistochemistry, and molecular testing, are essential for cancer diagnosis, staging, and treatment planning. According to the National Center for Health Statistics, it is estimated that in 2023, there will be 1,958,310 new cancer cases and 609,820 cancer-related deaths in the United States.

Enhanced funding for cancer research and the development of diagnostic technologies from both governmental and private sectors could further stimulate market growth. Nevertheless, concerns regarding data privacy may pose challenges to the market.

Tissue Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.4% over the forecast period (2024-2032)

Based on Technology segmentation, Immunohistochemistry was predicted to show maximum market share in the year 2023

Based on application segmentation, Breast Cancer was the leading type in 2023

Based on End-User segmentation, Hospitals was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Tissue Diagnostics Market- Segmentation Analysis:

The Global Tissue Diagnostics Market is segmented based on Technology, Application, End-User and Region.

The market is segmented into three distinct categories according to technology: immunohistochemistry, In Situ Hybridization, Primary & Special Staining, and Digital Pathology and Workflow. Immunohistochemistry holds a leading position in the market. It is crucial in tissue diagnostics, facilitating the thorough analysis of tissue samples for disease diagnosis, especially cancers, and assisting in treatment decision-making.

The market is segmented into five categories according to their applications: Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Cancer, and Others. Breast Cancer holds a leading position in the market. The tissue diagnostics sector for breast cancer is propelled by rising incidence rates, technological advancements, and an emphasis on early detection and personalized treatment approaches.

The market is segmented into three categories according to the end users: Hospitals, Research Laboratories, Pharmaceutical Companies, and Contract Research Organizations (CROs). Hospitals hold a dominant position in the market. The demand for tissue diagnostics within hospitals is propelled by the necessity for precise and prompt disease diagnosis and management.

Tissue Diagnostics Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further categorized based on the countries contributing to the business landscape. North America leads the market, primarily due to the high demand for advanced diagnostic products, including instruments and reagents. There is a notable requirement for sophisticated diagnostic tools and reagents in North America, which encompasses automated systems, digital pathology platforms, and advanced molecular diagnostic instruments that ensure high levels of accuracy and efficiency. The majority of the in vitro diagnostics (IVD) market is concentrated in developed nations, particularly in the United States, which accounts for approximately USD 19 billion.

Europe also plays a crucial role in the tissue diagnostics sector, experiencing steady growth fueled by the rising incidence of cancer, advanced healthcare infrastructures, and an increasing awareness of the importance of early diagnosis.

Tissue Diagnostics Market- Competitive Landscape:

The tissue diagnostics market exhibits a high level of competition, characterized by numerous prominent firms and emerging entities striving to secure market share through innovative solutions, diverse product offerings, and strategic initiatives. Organizations are dedicating resources to the advancement of cutting-edge technologies, including digital pathology, automated staining systems, and highly sensitive reagents. Firms with a robust global footprint and well-established distribution channels are positioned to compete effectively across different regional markets. Additionally, there is a focus on exploring new geographic territories and broadening product lines to enhance their presence in the tissue diagnostics sector.

Recent Developments:

In June 2024, Roche declared that its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has obtained 510(k) clearance from the United States Food and Drug Administration (FDA). This system is designed to assist pathologists in the review and interpretation of digital images derived from scanned pathology slides, thereby facilitating patient diagnosis.

In January 2023, Thermo Fisher Scientific announced its collaboration with AstraZeneca to create a companion diagnostic (CDx) test for Tagrisso (osimertinib), which will apply to both solid tissue and blood samples.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TISSUE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Siemens
  • Danaher
  • bioMerieux SA
  • QIAGEN
  • BD
  • Merck KGaA
  • GE Healthcare
  • BioGenex
  • Cell Signaling Technology, Inc.
  • Bio SB
  • DiaGenic ASA
  • Agilent Technologies
  • Others

GLOBAL TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Immunohistochemistry
  • Instruments
  • Slide Staining Systems
  • Tissue Microarrays
  • Tissue Processing Systems
  • Slide Scanners
  • Other Products
  • Consumables
  • Antibodies
  • Reagents
  • Kits
  • In Situ Hybridization
  • Instruments
  • Consumables
  • Software
  • Primary & Special Staining
  • Digital Pathology and Workflow
  • Whole Slide Imaging
  • Image Analysis Informatics
  • Information Management System Storage & Communication
  • Anatomic Pathology
  • Instruments
  • Microtomes & Cryostat Microtomes
  • Tissue Processors
  • Automatic Strainers
  • Other Products
  • Consumables
  • Reagents & Antibodies
  • Probes & Kits
  • Others

GLOBAL TISSUE DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Breast Cancer
  • Non-small Cell Lung Cancer
  • Prostate Cancer
  • Gastric Cancer
  • Other

GLOBAL TISSUE DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Research Laboratories
  • Pharmaceutical Organizations
  • Contract Research Organizations (CROs)

GLOBAL TISSUE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Tissue Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Tissue Diagnostics Market Snippet by Technology
    • 2.1.2. Tissue Diagnostics Market Snippet by Application
    • 2.1.3. Tissue Diagnostics Market Snippet by End-User
    • 2.1.4. Tissue Diagnostics Market Snippet by Country
    • 2.1.5. Tissue Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Tissue Diagnostics Key Market Trends

  • 3.1. Tissue Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Tissue Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Tissue Diagnostics Market Opportunities
  • 3.4. Tissue Diagnostics Market Future Trends

4. Tissue Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tissue Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tissue Diagnostics Market Landscape

  • 6.1. Tissue Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Tissue Diagnostics Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2. Immunohistochemistry
      • 7.1.2.1. Instruments
      • 7.1.2.1.1.1. Slide Staining Systems
      • 7.1.2.1.1.2. Tissue Microarrays
      • 7.1.2.1.1.3. Tissue Processing Systems
      • 7.1.2.1.1.4. Slide Scanners
      • 7.1.2.1.1.5. Other Products
      • 7.1.2.2. Consumables
      • 7.1.2.2.1.1. Antibodies
      • 7.1.2.2.1.2. Reagents
      • 7.1.2.2.1.3. Kits
    • 7.1.3. In Situ Hybridization
      • 7.1.3.1. Instruments
      • 7.1.3.2. Consumables
      • 7.1.3.3. Software
    • 7.1.4. Primary & Special Staining
    • 7.1.5. Digital Pathology and Workflow
      • 7.1.5.1. Whole Slide Imaging
      • 7.1.5.2. Image Analysis Informatics
      • 7.1.5.3. Information Management System Storage & Communication
      • 7.1.5.4. Anatomic Pathology
    • 7.1.6. Instruments
      • 7.1.6.1. Microtomes & Cryostat Microtomes
      • 7.1.6.2. Tissue Processors
      • 7.1.6.3. Automatic Strainers
      • 7.1.6.4. Other Products
    • 7.1.7. Consumables
      • 7.1.7.1. Reagents & Antibodies
      • 7.1.7.2. Probes & Kits
      • 7.1.7.3. Others

8. Tissue Diagnostics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Breast Cancer
    • 8.1.3. Non-small Cell Lung Cancer
    • 8.1.4. Prostate Cancer
    • 8.1.5. Gastric Cancer
    • 8.1.6. Other

9. Tissue Diagnostics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Research Laboratories
    • 9.1.4. Pharmaceutical Organizations
    • 9.1.5. Contract Research Organizations (CROs)

10. Tissue Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Tissue Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Tissue Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Tissue Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Tissue Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Tissue Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Tissue Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Thermo Fisher Scientific Inc.
    • 11.2.4. Siemens
    • 11.2.5. Danaher
    • 11.2.6. bioMerieux SA
    • 11.2.7. QIAGEN
    • 11.2.8. BD
    • 11.2.9. Merck KGaA
    • 11.2.10. GE Healthcare
    • 11.2.11. BioGenex
    • 11.2.12. Cell Signaling Technology, Inc.
    • 11.2.13. Bio SB
    • 11.2.14. DiaGenic ASA
    • 11.2.15. Agilent Technologies
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us